New algorithm created to support those with suicidal thoughts.

By Catherine Sturman
Share
The numbers of people who are taking their own lives across the world continues to rise, and has become a leading cause of death in adults in the US. Fr...

The numbers of people who are taking their own lives across the world continues to rise, and has become a leading cause of death in adults in the US. From lack of access to mental health services, amidst a large number of factors, scientists have now worked to develop a new programme which will support the diagnosis and identification of those who are suffering from suicidal thoughts.

The new algorithm will analyse people’s brain scans, and will support the growth and development of professional services surrounding mental health conditions.

A study conducted by Carnegie Mellon and the University of Pittsburgh incorporated over 30 volunteers, where 17 had suicidal thoughts whilst the others did not. Whilst undergoing a fMRI, they were each asked to read a number of words with both positive and negative connotations, and asked to think about the meaning surrounding these words.

Related stories

By analysing patients cerebral blood flows and the subsequent data activity, an algorithm was able to be constructed, and has led the system to gain the ability to ascertain those with suicidal thoughts with over 90% accuracy, alongside those who have attempted suicide in previous years at over 90%.

However, despite these advantages, one challenge which remains for patients are rising costs within the healthcare space. fMRI scans cost thousands to undertake, and are therefore not recommended by medical professionals unless absolutely necessary. Many hospitals will consequently not house such technology, and insurance plans rarely cover this type of medical procedure.

Nonetheless, the study could open doors to transforming our understanding of mental health and provide better support to those in need.

 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma